The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial — Osadnik et al. — Thorax

We found no evidence that PEP therapy during AECOPD improves important short-term or long-term outcomes. There does not appear to be a routine role for PEP therapy in the management of such individuals.

via The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial — Osadnik et al. — Thorax.

Advertisements

Respiratory Therapy May Lower Death Risk for Some Sleep Apnea Patients

Treatment with continuous positive airway pressure (CPAP) reduces the risk of death in people who suffer from both sleep apnea and a lung condition called chronic obstructive pulmonary disease (COPD), according to a new study.

via Respiratory Therapy May Lower Death Risk for Some Sleep Apnea Patients.

The effects of Provent on moderate to severe obstructive sleep apnoea during continuous positive airway pressure therapy withdrawal: a randomised controlled trial — Rossi et al. 68 (9): 854 — Thorax

Conclusions Provent cannot be recommended as an alternative short-term therapy for patients with moderate to severe OSA already on CPAP.

via The effects of Provent on moderate to severe obstructive sleep apnoea during continuous positive airway pressure therapy withdrawal: a randomised controlled trial — Rossi et al. 68 (9): 854 — Thorax.